[go: up one dir, main page]

HRP970165A2 - Novel asymmetric synthesis of r-alpha-propyl-piperonyl amine and its analogs - Google Patents

Novel asymmetric synthesis of r-alpha-propyl-piperonyl amine and its analogs

Info

Publication number
HRP970165A2
HRP970165A2 HR60/013,955A HRP970165A HRP970165A2 HR P970165 A2 HRP970165 A2 HR P970165A2 HR P970165 A HRP970165 A HR P970165A HR P970165 A2 HRP970165 A2 HR P970165A2
Authority
HR
Croatia
Prior art keywords
analogs
propyl
alpha
asymmetric synthesis
novel asymmetric
Prior art date
Application number
HR60/013,955A
Other languages
English (en)
Inventor
Hui-Yin Li
Luigi Anzalone
Robert Eugene Waltermeier
Original Assignee
Du Pont Merck Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont Merck Pharma filed Critical Du Pont Merck Pharma
Publication of HRP970165A2 publication Critical patent/HRP970165A2/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/58Radicals substituted by nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
HR60/013,955A 1996-03-22 1997-03-21 Novel asymmetric synthesis of r-alpha-propyl-piperonyl amine and its analogs HRP970165A2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1395596P 1996-03-22 1996-03-22

Publications (1)

Publication Number Publication Date
HRP970165A2 true HRP970165A2 (en) 1998-04-30

Family

ID=21762727

Family Applications (1)

Application Number Title Priority Date Filing Date
HR60/013,955A HRP970165A2 (en) 1996-03-22 1997-03-21 Novel asymmetric synthesis of r-alpha-propyl-piperonyl amine and its analogs

Country Status (23)

Country Link
US (1) US5932749A (fr)
EP (1) EP0888329A1 (fr)
JP (1) JP2000506891A (fr)
KR (1) KR20000064735A (fr)
CN (1) CN1218463A (fr)
AR (1) AR006521A1 (fr)
AU (1) AU719633B2 (fr)
BR (1) BR9708233A (fr)
CA (1) CA2249401A1 (fr)
CZ (1) CZ295098A3 (fr)
EA (1) EA001207B1 (fr)
EE (1) EE9800299A (fr)
HR (1) HRP970165A2 (fr)
IL (1) IL126223A0 (fr)
LT (1) LT4540B (fr)
LV (1) LV12259B (fr)
NO (1) NO984344L (fr)
NZ (1) NZ331875A (fr)
PL (1) PL329070A1 (fr)
SI (1) SI9720023A (fr)
SK (1) SK127398A3 (fr)
WO (1) WO1997034887A1 (fr)
ZA (1) ZA972342B (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5587299A (en) 1998-08-31 2000-03-21 Du Pont Pharmaceuticals Company An efficient process for the preparation of a human leukocyte elastase inhibitor
DE60238218D1 (de) * 2001-09-12 2010-12-16 Anormed Inc Synthese von enantiomerenreinen, aminosubstituierten kondensierten bicyclischen ringen
CA2743700C (fr) * 2008-12-15 2016-07-12 Taigen Biotechnology Co., Ltd. Synthese stereoselective de derives de piperidine
AR090100A1 (es) 2012-02-21 2014-10-22 Celgene Corp Procesos para la preparacion de la (s)-1-(3-etoxi-4-metoxifenil)-2-metanosulfoniletilamina
US9126906B2 (en) 2012-02-21 2015-09-08 Celgene Corporation Asymmetric synthetic processes for the preparation of aminosulfone compounds
US10953003B2 (en) 2015-12-14 2021-03-23 X4 Pharmaceuticals, Inc. Methods for treating cancer
EP3389652B1 (fr) 2015-12-14 2022-09-28 X4 Pharmaceuticals, Inc. Méthodes de traitement du cancer
ES2935834T3 (es) 2015-12-22 2023-03-10 X4 Pharmaceuticals Inc Métodos para tratar enfermedad de inmunodeficiencia
CA3019394A1 (fr) 2016-04-08 2017-10-12 X4 Pharmaceuticals, Inc. Methodes de traitement du cancer
WO2017223243A1 (fr) 2016-06-21 2017-12-28 X4 Pharmaceuticals, Inc. Inhibiteurs de cxcr4 et leurs utilisations
CN109640988A (zh) 2016-06-21 2019-04-16 X4 制药有限公司 Cxcr4抑制剂及其用途
CN109562106B (zh) 2016-06-21 2023-03-21 X4 制药有限公司 Cxcr4抑制剂及其用途
US10548889B1 (en) 2018-08-31 2020-02-04 X4 Pharmaceuticals, Inc. Compositions of CXCR4 inhibitors and methods of preparation and use
EP4117662A4 (fr) 2020-03-10 2024-04-03 X4 Pharmaceuticals, Inc. Méthodes de traitement de la neutropénie
CA3230380A1 (fr) 2021-09-01 2023-03-09 Nicholas MORRA Synthese de mdma ou de ses isomeres optiquement actifs (r)- ou (s)-mdma
US12492178B2 (en) 2021-09-01 2025-12-09 Empathbio, Inc. Stable polymorph of R-MDMA HCl
EP4401725A4 (fr) * 2021-09-17 2025-12-17 ATAI Life Sciences AG Préparation d'énantiomères optiquement actifs d'amines de pipéronyle par résolution des sels diastéréomères
WO2023056102A1 (fr) 2021-10-01 2023-04-06 ATAI Life Sciences AG Nouveaux promédicaments de mdma, mda et leurs dérivés
US11912680B2 (en) 2021-12-28 2024-02-27 Empathbio, Inc. Nitric oxide releasing prodrugs of MDA and MDMA

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3819438A1 (de) * 1987-06-30 1989-01-19 Basf Ag Verfahren zur herstellung von optisch aktiven 1-arylethylaminen
IL99658A0 (en) * 1990-10-15 1992-08-18 Merck & Co Inc Substituted azetidinones and pharmaceutical compositions containing them
US5149838A (en) * 1991-09-20 1992-09-22 Merck & Co., Inc. Intermediates for substituted azetidinones useful as anti-inflammatory and antidegenerative agents

Also Published As

Publication number Publication date
BR9708233A (pt) 2000-01-04
NO984344D0 (no) 1998-09-18
LV12259A (lv) 1999-04-20
NZ331875A (en) 2000-01-28
AU719633B2 (en) 2000-05-11
CA2249401A1 (fr) 1997-09-25
JP2000506891A (ja) 2000-06-06
US5932749A (en) 1999-08-03
ZA972342B (en) 1998-09-18
EE9800299A (et) 1999-06-15
NO984344L (no) 1998-09-18
AU2196897A (en) 1997-10-10
SK127398A3 (en) 1999-04-13
CN1218463A (zh) 1999-06-02
EP0888329A1 (fr) 1999-01-07
KR20000064735A (ko) 2000-11-06
CZ295098A3 (cs) 1999-03-17
AR006521A1 (es) 1999-09-08
EA199800844A1 (ru) 1999-02-25
IL126223A0 (en) 1999-05-09
LT98132A (en) 1999-03-25
PL329070A1 (en) 1999-03-15
LT4540B (lt) 1999-08-25
SI9720023A (sl) 1999-04-30
EA001207B1 (ru) 2000-12-25
LV12259B (en) 1999-09-20
WO1997034887A1 (fr) 1997-09-25

Similar Documents

Publication Publication Date Title
IL126223A0 (en) Novel asymmetric synthesis of r-alpha-propyl-piperonyl amine and its analogs
HUP9802566A3 (en) 4-chloro-2-[1-hydroxy-1-trifluoromethyl-3-cyclopropyl-2-propyn-yl]-aniline derivatives and asymmetric synthesis thereof
GR3032200T3 (en) Improved synthesis of cyclopropylacetylene
ZA981887B (en) Synthesis of tertiary amine oxides
ZA965853B (en) Asymmetric synthesis of r and s warfarin and its analogs.
EP1021407A4 (fr) Synthese de clasto-lactacystine beta-lactone et de ses analogues
IL126272A0 (en) Synthesis of indolylmaleimides
EP0766662A4 (fr) Synthese asymetrique de (r)- et (s)-arylethanolamines depuis des iminocetones
GB9600774D0 (en) Waveform synthesis
IL128376A0 (en) Synthesis of bisindolylmalimides
IL130125A (en) Preparation of n-substituted 3-hydroxypyrazoles
GB9602343D0 (en) Production of alumina
GB9512632D0 (en) Asymmetric synthesis of tetrahydronaphthalene analogs
BR9708718A (pt) Sínteses de aminas substituídas
ZA95694B (en) Novel derivatives of tetramethylcyclopropane
IL134921A0 (en) NOVEL ASYMMETRIC SYNTHESIS OF R-α-PROPYL-PIPERONYL AMINE AND ITS ANALOGS
EP0923519A4 (fr) Synthese de l'haloalkynol
LT99070A (en) Asymmetric synthesis of benzoxazones
GB9719236D0 (en) Production of aminophenols
IL118238A0 (en) Synthesis of benzoquinolinones
IL122213A0 (en) Synthesis of deoxypyridinoline
GB9712820D0 (en) Synthesis of amino furandiones
GB2393957B (en) Synthesis of hexaazaisowurtzitane derivatives
PL303254A1 (en) Novel alkoxymethylammonium chlorides - derivatives of substituted benzylamine
PL303253A1 (en) Novel alkyammonium salts - derivatives of substituted benzylamine

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
PNAN Change of the applicant name, address/residence

Owner name: DUPONT PHARMACEUTICALS COMPANY, US

ODBC Application rejected